Genetic Technologies Limi... (GENE)
Genetic Max Pain By Strike
GENE trades at $0.77, 98.9% below the near-term max pain of $70 expiring Dec 18, 2026 (476 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is stable across expirations ($70-$70), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
Genetic Max Pain By Expiry
Max pain for GENE shows stable levels around 70.00, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels above 0.77 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Dec 18, 2026 | 70 | 69.23 (9050.33%) |